As of November 1, 2022, there were 55,894,875 shares of the registrant’s common stock, par value of $0.0001 per share, outstanding.
PART I. FINANCIAL INFORMATION
SOLAREDGE TECHNOLOGIES INC.
561,352
224,169
2,451,773
38,268
108,860
1,451,773
3,903,546
F - 2
311,565
181,892
694,480
15,570
1,156,939
(128,266
(27,319
723,008
2,052,127
F - 3
Other income
34,172
53,081
24,743
72,950
0.44
1.33
0.43
1.29
The accompanying notes are an integral part of the condensed consolidated financial statements.
F - 4
(9,579
(23,647
(140
(4,656
(38,646
(100,947
(13,903
(27,997
F - 5
Common stock
Additional
Issuance of Common Stock upon exercise of stock-based awards
Stock based compensation
Other comprehensive loss adjustments
Net income
Balance as of September 30, 2022
F - 6
Balance as of September 30, 2021
F - 7
(in thousands, except per share data)
(7,533
(3,822
(485
64,662
(188,579
(55,478
(377,089
53,683
12,119
82,025
41,440
67,789
(80,016
(125,085
(461,491
Investment in a privately-held company
(16,643
24,175
-
Withdrawal from bank deposits, net
50,020
Payment for asset acquisition, net of cash acquired
(2,996
3,472
(380,514
)
F - 8
650,526
(104
3,508
6,128
(4,686
(8,402
(2,109
647,135
186,605
530,089
(38,365
678,329
43,274
F - 9
The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions. The Company now offers a variety of energy solutions, which include lithium-ion cells, batteries, and energy storage systems (“Energy Storage”), full powertrain kits for electric vehicles, or EVs (“e-Mobility”), as well as automated machines for industrial use (“Automation Machines”).
F - 10
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
F - 11
F - 12
F - 13
NOTE 5: DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
As of September 30, 2022, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) for NIS in the amount of approximately NIS 334 million and NIS 10 million, respectively.
In addition to the above-mentioned cash flow hedge transactions, the Company also entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, under "Financial expense, net".
The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.
As of September 30, 2022, the Company entered into forward contracts to sell Australian dollars (“AUD”) for USD in the amount of AUD 4 million.
As of September 30, 2022, the Company entered into forward contracts to sell Euro for USD in the amount of €9 million.
The fair values of outstanding derivative instruments were as follows:
F - 14
Gains (losses) on derivative instruments recognized in our income statements are summarized below:
Three Months Ended
September 30,
Nine Months Ended
2022
2021
Affected line item
Foreign exchange contracts
Non Designated Hedging Instruments
$1,211
$3,350
$5,154
$7,706
Financial expenses, net
See Note 13 for information regarding gains (losses) from designated hedging instruments reclassified from accumulated other comprehensive loss.
Gains (losses) on derivative instruments recognized in the consolidated comprehensive income (loss) statements were as follows:
Three Months EndedSeptember 30,
Nine Months EndedSeptember 30,
Foreign exchange contracts:
Designated Hedging Instruments
$
(1,399
1,006
(8,928
1,719
F - 15
F - 16
F - 17
F - 18
F - 19
The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to 15% of their salaries to purchase common stock up to an aggregate limit of $15 per participant for every six months plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.
F - 20
The Company capitalized stock-based compensation as part of inventories and prepaid expenses for the three and nine months ended September 30, 2022, in the amount of $881 and $977, respectively. In 2021 the Company did not capitalize any stock- based compensation expenses.
The total tax benefit associated with share-based compensation for the three months ended September 30, 2022 and 2021 was $2,646 and $3,791, respectively. The tax benefit realized from share-based compensation for the three months ended September 30, 2022, and 2021 was $3,060 and $4,720, respectively.
The total tax benefit associated with share-based compensation for the nine months ended September 30, 2022, and 2021 was $9,182 and $10,249, respectively. The tax benefit realized from share-based compensation for the nine months ended September 30, 2022, and 2021 was $8,871 and $10,400, respectively.
As of September 30, 2022, there were total unrecognized compensation expenses in the amount of $279,982 related to non-vested equity-based compensation arrangements granted under the Company’s plans and non-plan awards. These expenses are expected to be recognized during the period from October 1, 2022, through August 31, 2026.
F - 21
The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.
F - 22
F - 23
Unrealized gains (losses) on available-for-sale marketable securities
Unrealized gains (losses) on cash flow hedges, net
Sale of property, plant and equipment
Sale of Critical Power assets
F - 24
NOTE 15: INCOME TAXES
The effective tax rate for the three months ended September 30, 2022, and 2021 was 58.0% and 12.6%, respectively, and for the nine months ended September 30, 2022, and 2021 the effective tax rate was 42.1% and 15.9%, respectively.
The increase in the effective tax rate in the current year, is primarily due to the change to Section 174 of the U.S Internal Revenue Code, which came into effect on January 1, 2022. The change requires taxpayers to amortize research and development expenditures over five years (if expensed by a U.S. entity) or fifteen years (if expensed by non-U.S. entities). This change resulted in an increase in the Company’s taxable income and Global Intangible Low Taxed Income (“GILTI”) tax. In addition, the change in the Company's tax rate resulted from a different allocation of income among the Company’s U.S., Israeli, and foreign subsidiaries, and lower tax benefits relating to stock-based compensation.
As of September 30, 2022, and December 31, 2021, unrecognized tax benefits were $2,561 and $2,192, respectively. If recognized, such benefits would favorably affect the Company’s effective tax rate.
The Company accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount of penalties and interest were immaterial as of September 30, 2022, and December 31, 2021.
In August 2022, the U.S. government signed into law the Inflation Reduction Act of 2022 (the “IRA”), which, among other things, revised U.S. tax law by, including a new corporate alternative minimum tax (the “CAMT”) of 15% on certain large corporations, imposing a 1% excise tax on stock buybacks, and providing incentives to address climate change, including the introduction of advanced manufacturing production tax credits, that may be relevant to the company's products, if they will be manufactured in the US. The provisions of the IRA are generally effective for tax years beginning after 2022. Given the complexities of the IRA, which is pending technical guidance and regulations from the Internal Revenue Service and U.S. Treasury Department, the Company is in the process of evaluating provisions included under the IRA and its impact to the Company’s consolidated financial statements.
F - 25
F - 26
F - 27
Amortization related to business combinations
(2,559
(2,785
(8,039
(8,007
NOTE 18: SUBSEQUENT EVENTS
On November 3, 2022, the Company received notice that a class action lawsuit was filed in the U.S District Court of the Southern District of New York against the Company, SolarEdge Technologies Ltd., the Company’s CEO and the Company’s CFO, by a purported stockholder of the Company, alleging violations of the Federal Securities Act in connection with complaints filed against the Company by Ampt LLC, the details for which can be found under “Note 12- Commitments and Contingent Liabilities”. The Company believes the allegations contained in this new action are without merit and intends to vigorously defend against them.
F - 28